Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
telmisartan + rosuvastatin
- Development stage
- Phase 4
- Lead developer
- Yuhan
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Telmisartan + rosuvastatin is a fixed-dose combination drug used to treat patients with both hypertension (high blood pressure) and hyperlipidemia (high cholesterol). It combines two active pharmaceutical ingredients: - **Telmisartan** is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II on its receptor. This leads to relaxation and widening of blood vessels. - **Rosuvastatin** is a statin (HMG-CoA reductase inhibitor) that reduces cholesterol levels by inhibiting the enzyme HMG-CoA reductase in the liver. This decreases production of "bad" LDL cholesterol and triglycerides while increasing "good" HDL cholesterol. The combination helps reduce cardiovascular risk in patients who require both antihypertensive and lipid-lowering therapy. It is available as an oral tablet for adult use[1][5][8].
- Brand names
- Tellzy-RST-Mart RRozution-TTelmidoz-RTelihep RSTelmirose RTTelroseBriztelTelosaf RVTelmade RS
- Other names
- telmisartan + rosuvastatin
02
Targets
AGTR1 (Angiotensin II Type-1 receptor)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on telmisartan + rosuvastatin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on telmisartan + rosuvastatin.